Last updated 30 days ago
A Clinical Study of MK-2870 Alone or With Chemotherapy to Treat Gastrointestinal Cancers (MK-9999-02A)
130 patients around the world
Available in Chile
Merck Sharp & Dohme LLC
4Research sites
130Patients around the world
This study is for people with
Colorectal cancer
Requirements for the patient
From 18 Years
All Gender
Medical requirements
- Has one of the following cancers.Unresectable or metastatic colorectal cancer.Advanced or metastatic pancreatic ductal adenocarcinoma (PDAC).Advanced and/or unresectable biliary tract cancer (BTC).Has received prior therapy for the cancer.Has recovered from any side effects due to previous cancer treatment.
- History of severe eye disease.Received prior systemic anticancer therapy including investigational agents within 4 weeks before starting study intervention.History of (noninfectious) pneumonitis/interstitial lung disease that required steroids or has current pneumonitis/interstitial lung disease.
Sites
Centro de Investigación Clínica Bradford Hill - Santiago, Región Metropolitana
Recruiting
James Lind Centro de Investigación del Cáncer - Temuco
Recruiting
Instituto Oncológico FALP - UIDO
Recruiting
Clínica San Carlos de Apoquindo - Red de Salud UC Christus
Recruiting
SponsorMerck Sharp & Dohme LLC
Conditions
Colorectal cancer
Requirements
From 18 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06428409
